Nobutaka Ida

Title: **Nobutaka Ida: Innovator in Uremia Treatment**

Introduction

Nobutaka Ida is a prominent inventor based in Kamakura, Japan, known for his significant contributions to the field of medical treatment, particularly in ameliorating the symptoms of uremia. With a portfolio of three patents, Ida has developed innovative methods that showcase the intersection of medical science and practical application.

Latest Patents

Nobutaka Ida’s latest patents focus on advancing therapeutic approaches for uremia. His foremost invention, titled "Method of ameliorating uremia," details a method that includes administering a therapeutic agent containing beraprost or its isomers as an effective treatment for canines. The method emphasizes the need for an effective dosage that does not significantly lower blood pressure in the treated animals.

Another significant patent, "Therapeutic agent and treatment method for ameliorating uremia," addresses therapies for both humans and animals suffering from chronic renal failure. This invention introduces a prostaglandin I derivative, specifically beraprost sodium, as an effective ingredient. Ida’s therapeutic agent aims to ameliorate uremic symptoms with minimal side effects and at a reasonable cost, leading to improvements in appetite and activities in patients suffering from renal failure.

Career Highlights

Nobutaka Ida has made noteworthy strides in his career with Toray Industries, Inc., where he applies his expertise in medical innovations. His commitment to advancing treatment options for uremia has not only contributed to the scientific community but also positively impacted patient care.

Collaborations

Throughout his career, Ida has collaborated with notable colleagues such as Masahiko Takenaka and Yoshihisa Yamane. These collaborations underscore the importance of teamwork in the research and development of effective medical treatments, leading to enhanced innovations in their respective fields.

Conclusion

Nobutaka Ida stands out as a pioneering inventor dedicated to tackling the challenges associated with uremia. His innovative patents reflect a deep understanding of medical needs and a commitment to producing viable solutions that benefit both human and animal patients alike. With his continued work, Ida is sure to leave a lasting legacy in the realm of therapeutic advancements.